Members |
targetComponentId |
Treatment of glaucoma |
Medicinal product acting as antiglaucoma agent (product) |
Treponema pallidium |
Treponema pallidum |
tretinoin 0,05 %, vätska |
Tretinoin 500 microgram/mL cutaneous solution |
Trial of micturition without catheter |
Trial without catheter |
triamcinolonacetinoid 100 mikrogram/sprejdos |
Product containing only triamcinolone (medicinal product) |
triamcinolonacetonid 3 mg, injektionsvätska, suspension, ampull 1 ml |
Triamcinolone acetonide 3 mg/mL suspension for injection |
triamcinolonacetonid 40 mg, injektionsvätska, suspension, ampull |
Triamcinolone only product in parenteral dose form |
triamcinolonacetonid 40 mg/ml, suspension |
Product containing only triamcinolone (medicinal product) |
triamcinolondiacetat 25 mg/ml, injektionsvätska, suspension, ampull |
Triamcinolone diacetate 25 mg/mL suspension for injection |
triamcinolondiacetat 40 mg/ml, injektionsvätska, suspension, ampull |
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
ribavirin 6 g, pulver för beredning av inhalationsvätska |
Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
recessiv kongenital iktyosiform erytrodermi |
Trichothiodystrophy (disorder) |
Trichoglossus haematodos forsteni |
Trichoglossus forsteni (organism) |
Trichomoniasis of other sites |
Infection by Trichomonas |
Trichosporon capitatum |
Saprochaete capitata |
natriumtriklofosallergi |
Allergy to triclofos |
triklosan 2 %, badtillsats |
Triclosan 20 mg/mL cutaneous solution |
trietanolaminpolypeptidoleatkondensat 10 %, lösning |
Product containing only triethanolamine in otic dose form (medicinal product form) |
Trifluoperazine hydrochlorid 1mg tablet |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
Trifluoperazine hydrochlorid 5mg tablet |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
trifluoperazinhydroklorid 10 mg/ml, lösning |
Trifluoperazine 10 mg/mL oral solution |
trihexyfenidylhydroklorid 5 mg, kapsel med modifierad frisättning |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
trihexyfenidylhydroklorid 5 mg, depåkapsel |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
extrakt specifikt för bensentrikarboxylsyraanhydrid |
Trimellitic acid |
trimestrar |
Maternal antenatal period |
Trimethobenzamide 100mg/mL |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
Trimethobenzamide hydrochlor 100mg/mL solution |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
trimetobensamidhydroklorid 100 mg/ml, intramuskulär lösning |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
trimetobensamidhydroklorid 100 mg |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
Trimethobenzamide hydrochloride 100mg/mL bar |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
trimetobensamidhydroklorid 100 mg/ml, injektionsvätska, lösning, ampull |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
trimetobensamidhydroklorid 200 mg, suppositorium |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) |
trotyl |
Trinitrotoluene (substance) |
trifalangeala tummar med missbildning av nagel |
Deafness, onychodystrophy, osteodystrophy, intellectual disability syndrome (disorder) |
Triphosphoric monoester hydrolase |
Triphosphoric monoester hydrolase |
triptorelinpamoat 11,25 mg/flaska, frystorkat pulver till injektionsvätska, suspension |
Triptorelin only product in parenteral dose form |
triptorelinpamoat 11,25 mg, pulver i flaska |
Triptorelin only product in parenteral dose form |
triptorelinpamoat 3,75 mg/flaska, frystorkat pulver till injektionsvätska, suspension |
Triptorelin only product in parenteral dose form |
triptorelinpamoat 3,75 mg, pulver i flaska |
Triptorelin only product in parenteral dose form |
trinatriumedetatallergi |
Allergy to edetate (finding) |
Tritiarchium |
Tritirachium |
Tritiarchium oryzae |
Tritirachium oryzae |
Trophic ulcer |
Neurogenic ulcer |
tropikamid 0,5 %, ögondroppar |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
tropikamid 0,5 %, ögondroppar för engångsbruk |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
tropikamid 1 %, ögondroppar |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
tropikamid 1 %, ögondroppar för engångsbruk |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
öring, livsmedel |
Trout (substance) |
True bug |
Order Hemiptera (organism) |
True histiocytic lymphoma |
Histiocytic sarcoma |
trypanblått 0,06 %, lösning för oftalmiskt bruk |
Trypan blue stain only product |
trypanblått 1,5 mg/ml, lösning för oftalmiskt bruk |
Trypan blue stain only product |
Tryptase |
Tryptase |
Tsukamurella wratislaviensis |
Rhodococcus wratislaviensis (organism) |
tubarabort |
Miscarriage of tubal ectopic pregnancy |
PPD-tuberkulin 100 000 enheter/ml, injektionsvätska, lösning, ampull 1 ml |
Product containing precisely tuberculin purified protein derivative 100000 unit/1 milliliter conventional release solution for injection (clinical drug) |
PPD-tuberkulin 1:10 000 (10 enheter/ml), injektionsvätska, lösning, ampull 1 ml |
Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
PPD-tuberkulin 1:100 (1 000 enheter/ml), injektionsvätska, lösning, ampull 1 ml |
Tuberculin purified protein derivative 1000 unit/mL solution for injection |
PPD-tuberkulin 1:1 000 (100 enheter/ml), injektionsvätska, lösning, ampull 1 ml |
Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
tuberkulin, renat protein 1 enhet/ml, injektionsvätska, lösning, flaska |
Tuberculin purified protein derivative 50 unit/mL solution for injection |
Tuberculosis of cervical lymph nodes |
Cervical tuberculous lymphadenitis |
Tuberculosis of other female genital organs |
Tuberculosis of female genital organs |
Tuberculosis of other specified bone |
Tuberculosis of bone |
Tuberculosis of other urinary organs (disorder) |
Primary progressive tuberculosis |
Tuberculosis of other urinary organs |
Tuberculosis of urinary organs |
Tuberculosis of peritoneum |
Tuberculous peritonitis |
Tuberculous |
Tuberculous (qualifier value) |
Tuberculous spondylitis |
Tuberculosis of vertebral column |
tubulärt adenom, kategori |
Benign tubular adenoma (morphologic abnormality) |
tubulärt adenom |
Benign tubular adenoma (morphologic abnormality) |
cervikal spondylos på två nivåer med myelopati |
Myelopathy due to two-level cervical spondylosis |
cervikal spondylos på två nivåer med radikulopati |
Radiculopathy due to two-level cervical spondylosis (disorder) |
Tyverb |
Product containing lapatinib (medicinal product) |
Tympanosclerosis involving other combination of structures |
Tympanosclerosis |
Type B oncovirus group |
Genus Betaretrovirus (organism) |
Type B oncovirus group |
Genus Betaretrovirus (organism) |
Type C oncovirus group |
Genus Gammaretrovirus (organism) |
Type D retrovirus group |
Genus Betaretrovirus (organism) |
Type I diabetes mellitus with multiple complications |
Disorder due to type 1 diabetes mellitus |
Type of anesthetic |
Type of anesthetic (observable entity) |
typer av emboli |
Embolus |
Types of fractures |
Fracture |
Types of insulin |
Insulin-containing product |
biverkning av vaccin med tyfoidpolysackarid |
Adverse reaction to typhoid vaccine |
biverkning av helcellsvaccin mot tyfoid |
Adverse reaction to typhoid vaccine |
U wave |
U wave feature |
Uele colobus |
Genus Colobus (organism) |
Ulcer due to Borrelia vincentii |
Ulcer due to Treponema vincentii |
Ulcers of yaws |
Nodular late yaws |
ultrarapid metaboliserare på grund av cytokrom P450, variant CYP2D6 |
Cytochrome P450 family 2 subfamily D member 6 ultra-rapid metabolizer (finding) |
kopplingsgel för ultraljud |
Ultrasound coupling gel |
Ultrasound procedure |
Ultrasonography |
Ultrasound scan - multiple fetus (observable entity) |
Ultrasound scan - multiple fetus (finding) |
Umbilical cord of intertwined twins |
Entanglement of cords of twins in monoamniotic sac |
vanvårdande miljö |
Uncaring environment |
Uncertain neoplastic process |
Neoplasm of uncertain behaviour |
icke-stimulerande miljö |
Unchallenging environment (finding) |
oklassificerad samlagsställning |
Coital position |
Unclassified ultrastructural features |
Subcellular structure |
Undetermined |
Indeterminate |
oväntat svår intubation |
Unexpected difficult tracheal intubation (finding) |